Position in JNJ
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$13,796,411
+$153,971 QoQ
Shares Held
54,323
-2.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.71%
of 13F equity value
Holder Rank
#930
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Johnson Financial Group, Inc. holds $42,713,684 across 13 Drug Manufacturers - General names. JNJ ranks #1 (32.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
54,323 | $13,796,411 | |
| 2 | LLY |
ELI LILLY & Co
|
7,447 | $8,932,155 | |
| 3 | ABBV |
AbbVie Inc.
|
33,931 | $8,538,396 | |
| 4 | MRK |
Merck & Co., Inc.
|
21,390 | $2,748,614 | |
| 5 | AMGN |
Amgen Inc
|
7,380 | $2,672,444 | |
| 6 | PFE |
Pfizer Inc
|
106,460 | $2,563,555 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
16,791 | $2,121,374 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
21,307 | $1,227,708 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $13,796,411 | 54,323 | Shares | Defined | 2026-08-10 | |
| 2026-03-31 | $13,642,440 | 55,811 | Shares | Defined | 2026-05-07 | |
| 2025-12-31 | $12,301,107 | 59,440 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $11,576,882 | 62,436 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $9,573,147 | 62,672 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $10,169,805 | 61,323 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $8,494,399 | 58,736 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $9,957,776 | 61,445 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $8,718,297 | 59,649 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $5,646,590 | 35,695 | Shares | Defined | 2024-05-14 | |
| 2023-12-31 | $4,967,717 | 31,694 | Shares | Defined | 2024-02-09 | |
| 2023-09-30 | $5,649,052 | 36,270 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $6,667,144 | 40,280 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,679,260 | 43,092 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $6,753,857 | 38,233 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $6,196,407 | 37,931 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $8,273,207 | 46,607 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $8,677,179 | 48,960 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $8,082,542 | 47,247 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $7,706,618 | 47,719 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $8,429,415 | 51,168 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $7,660,845 | 46,613 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $7,089,653 | 45,048 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $6,664,909 | 44,767 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $5,882,973 | 41,833 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $5,735,625 | 43,740 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||